vinpocetine has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahman, RS; Abozaid, AM; Elnfarawy, AA; Elweshahy, RH; Komber, IF; Nashy, AE | 1 |
| Abdelsalam, RM; Ahmed, LA; El-Khatib, AS; Essam, RM | 1 |
2 other study(ies) available for vinpocetine and Cirrhosis, Liver
| Article | Year |
|---|---|
Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats.
Topics: Animals; Glutathione; Interleukin-6; Liver; Liver Cirrhosis; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley; Superoxide Dismutase; Thioacetamide; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2021 |
Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways.
Topics: Aminopyridines; Animals; Benzamides; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Liver Cirrhosis; Male; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4; Vinca Alkaloids | 2019 |